The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated phase I trial of anti-LAG-3 or anti-CD137 alone and in combination with anti-PD-1 in patients with recurrent GBM.
 
Michael Lim
Stock and Other Ownership Interests - SQZ Biotechnology
Honoraria - Accuray; Agenus; Bristol-Myers Squibb; Merck; Oncorus; Stryker
Consulting or Advisory Role - Accuray; Baxter; Bristol-Myers Squibb; Merck; Stryker; VBI Vaccines
Research Funding - Accuray (Inst); Agenus (Inst); Arbor Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); CellDex (Inst); ImmunoCellular Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Methods Patent for Combining Immunotherapy with Radiation (Inst)
Travel, Accommodations, Expenses - Accuray; Baxter; Bristol-Myers Squibb; Merck; Stryker
 
Xiaobu Ye
No Relationships to Disclose
 
Anna F. Piotrowski
No Relationships to Disclose
 
Arati Suvas Desai
No Relationships to Disclose
 
Manmeet Singh Ahluwalia
Stock and Other Ownership Interests - doctible; MimiVax
Honoraria - Elsevier; Prime Education; Prime Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; CBT Pharmaceuticals; Flatiron Health; Kadmon; Karyopharm Therapeutics; Monteris Medical; Varian Medical Systems; VBI Vaccines
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst)
 
Tobias Walbert
Consulting or Advisory Role - Abbvie; Tocagen
Travel, Accommodations, Expenses - NovoCure; Tocagen
 
Joy D. Fisher
No Relationships to Disclose
 
Serena Desideri
No Relationships to Disclose
 
Zineb Belcaid
No Relationships to Disclose
 
Christina Jackson
No Relationships to Disclose
 
Louis B. Nabors
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Merck/Schering Plough
Travel, Accommodations, Expenses - Merck/Schering Plough
 
Patrick Y. Wen
Consulting or Advisory Role - AbbVie; Agios; AstraZeneca; Deciphera; Genentech/Roche; GW Pharmaceuticals; Immunomic Therapeutics; KIYATEC; Lilly; Puma Biotechnology; Taiho Pharmaceutical; Tocagen; Vascular Biogenics; VBI Vaccines; ZIOPHARM Oncology
Speakers' Bureau - Merck; Prime Oncology
Research Funding - Abbvie (Inst); Agios (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Beigene (Inst); Genentech/Roche (Inst); Kazia Therapeutics (Inst); Lilly (Inst); MediciNova (Inst); Merck (Inst); Novartis (Inst); Oncoceutics (Inst); Vascular Biogenics (Inst); Vascular Biogenics (Inst); VBI Vaccines (Inst)
 
Stuart A. Grossman
Stock and Other Ownership Interests - Axxia Pharmaceuticals
Consulting or Advisory Role - Abbvie; Medicenna; Midatech Pharma
Patents, Royalties, Other Intellectual Property - Patent related to a subcutaneous polymeric opioid delivery system have been awarded.